台股 » 個股 » 華上 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

華上

(6289)
  • 股價
    1.35
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    0
  • 產業
    上市 發光二極體(LED)
  • 27人加入追蹤

    立即追蹤

  • 本地時間:14:35(已收盤)

     
華上 (6289)籌碼相關-大昌-樹林 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

大昌-樹林 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2022/09/0100.002.10.800.94-2.1206-1.00%
2022/08/3100.0032.80.720.86-32.8160-20.39%
2022/08/3000.0010.790.79-187-1.15%
2022/04/0700.0023.153.09-2207-0.96%
2022/04/0600.0003.103.150208-0.01%
2021/07/2200.000.23.203.19-0.269-0.32%
2021/04/2100.0023.603.58-297-2.04%
2021/04/1600.0023.773.66-291-2.18%
2021/04/0803.0700.003.070830.00%
2021/03/190.32.9500.002.940.3830.37%
2021/03/180.62.9600.002.950.6830.77%
2021/02/240.13.0100.003.000.1860.06%
2021/02/1823.0500.003.052882.26%
2021/02/0113.3400.002.741901.11%
2020/10/0654.5000.004.5053421.46%
2020/09/2855.3000.005.1953101.61%
2020/09/25155.7600.005.76153004.99%
2020/09/2457.7200.006.4052911.71%
2020/09/1500.0014.924.04-1188-0.53%
2020/09/1400.0034.484.48-3159-1.88%
2020/09/0700.002.32.712.80-2.3108-2.08%
2020/08/030.22.0300.002.050.2770.26%
2020/03/1221.8700.001.8722620.76%
2020/03/1002.3000.002.3002740.00%
2020/01/1500.000.80.800.84-0.8272-0.28%
2019/12/1230.9900.001.0032321.29%
2019/07/1600.0060.550.55-6125-4.78%
2019/06/2000.6700.000.6802030.00%
2019/03/2901.0000.001.0101390.00%
2019/03/2500.9900.001.0501400.00%
2019/03/2201.0200.001.0701450.00%
2019/03/2000.0051.141.10-5146-3.41%
2019/03/1901.1000.001.1001480.00%
2019/03/1401.0100.001.0201450.00%
2019/03/1301.0500.001.0701460.00%
2019/02/2751.1600.001.1451293.87%
2019/02/1501.3600.001.3801090.00%
2018/12/1000.0051.221.21-580-6.22%
2018/06/2700.0051.681.68-5124-4.03%
2018/04/2700.0001.911.9601120.00%
2018/04/1601.9600.001.9601130.00%
2018/03/3000.000.11.972.07-0.197-0.06%
2018/03/1602.0500.002.070960.00%
2018/03/1302.1200.002.1201000.00%
2018/03/1202.1400.002.1201020.00%
2018/02/1200.0032.162.10-3127-2.35%
2018/01/3122.2700.002.2521331.49%
2018/01/2402.0800.002.1901310.00%
乳癌新藥剋必達上市 華上生醫IPO時程加速Anue鉅亨-2023/09/12
〈華上生醫展望〉乳癌新成分新藥拓展新適應症 肝癌試驗拚年底完成Anue鉅亨-2023/09/08
華上 相關文章